Evidence map›Paper›PMID 29524673›Full record

ArticleActa biomaterialia2018

Glaucomatous cell derived matrices differentially modulate non-glaucomatous trabecular meshwork cellular behavior.

Vijay Krishna Raghunathan, Julia Benoit, Ramesh Kasetti, Gulab Zode, Michelle Salemi, Brett S Phinney, Kate E Keller, Julia A Staverosky, Christopher J Murphy, Ted Acott and 1 more

Abstract read
In one paragraph

Article in Acta biomaterialia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vijay Krishna RaghunathanDepartment of Basic Sciences, College of Optometry, University of Houston, Houston, TX 77204, United States; The Ocular Surface Institute, College of Optometry, University of Houston, Houston, TX 77204, United States. Electronic address: vraghunathan@uh.edu.
Julia BenoitDepartment of Basic Sciences, College of Optometry, University of Houston, Houston, TX 77204, United States; Texas Institute for Measurement, Evaluation, and Statistics, College of Optometry, University of Houston, Houston, TX 77204, United States.
Ramesh KasettiNorth Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, United States.
Gulab ZodeNorth Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, United States.
Michelle SalemiUniversity of California Davis Genome Center Proteomics Core Facility, University of California Davis, Davis, CA 95616, United States.
Brett S PhinneyUniversity of California Davis Genome Center Proteomics Core Facility, University of California Davis, Davis, CA 95616, United States.
Kate E KellerDepartment of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, OR 97239, United States.
Julia A StaveroskyDepartment of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, OR 97239, United States.
Christopher J MurphyDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California Davis, Davis, CA 95616, United States; Department of Ophthalmology and Vision Sciences, School of Medicine, University of California Davis, Davis, CA 95616, United States.
Ted AcottDepartment of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, OR 97239, United States.
Janice VrankaDepartment of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, OR 97239, United States.

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
BIOLOGY OF TRABECULAR RESPONSE TO LASER TRABECULOPLASTYR01EY008247 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ACOTT, TED S · 1989 to 2017
$7.7M
VERTEBRATE EYE: STUDIES OF AQUEOUS OUTFLOWR01EY003279 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ACOTT, TED S · 1985 to 2012
$5.5M
Extracellular Matrix and Outflow ResistanceR01EY019643 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI KELLER, KATE E · 2010 to 2025
$5.0M
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of GlaucomaR01EY026177 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ZODE, GULAB · 2016 to 2025
$3.8M
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure HomeostasisR01EY025721 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ACOTT, TED S · 2015 to 2022
$2.8M
Mechanotransduction in Aqueous Outflow Regulation and Open Angle GlaucomaR01EY026048 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ACOTT, TED S, RAGHUNATHAN, VIJAYKRISHNA · 2018 to 2021
$1.5M
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAGR01EY028616 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ZODE, GULAB · 2018 to 2021
$1.4M
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY003279NEI NIH HHS R01 EY008247NEI NIH HHS R01 EY019643NEI NIH HHS R01 EY025721NEI NIH HHS R01 EY026048NEI NIH HHS R01 EY026177NEI NIH HHS R01 EY028616
6 · The paper itself

Abstract

Ocular hypertension is a causal risk-factor to developing glaucoma. This is associated with stiffening of the trabecular meshwork (TM), the primary site of resistance to aqueous-humor-outflow. The mechanisms underlying this stiffening or how pathologic extracellular matrix (ECM) affects cell function are poorly understood. It is recognized that mechanotransduction systems allow cells to sense and translate the intrinsic biophysical properties of ECM into intracellular signals to control gene transcription, protein expression, and cell behavior. Using an anterior segment perfusion model, we document that there are significantly more low flow regions that are much stiffer, and fewer high flow regions that are less stiff in glaucomatous TM (GTM) when compared to non-glaucomatous TMs (NTM). GTM tissue also has fewer cells overall when compared with NTM tissue. In order to study the role of pathologic ECM in glaucoma disease progression, we conducted studies using cell derived matrices (CDM). First, we characterized the mechanics, composition and organization of fibronectin in ECM deposited by GTM and NTM cells treated with glucocorticosteroids. Then, we determined that these GTM-derived ECM are able to induce stiffening of normal NTM cells, and alter their gene/protein expression to resemble that of a glaucomatous phenotype. Further, we demonstrate that GTM-derived ECM causes endoplasmic reticular stress in NTM. They also became resistant to being reorganized by these NTM cells. These phenomena were exacerbated by ECMs obtained from steroid treated glaucoma model groups. Collectively, our data demonstrates that CDMs represent a novel tool for the study of bidirectional interactions between TM cells and their immediate microenvironment. STATEMENT OF SIGNIFICANCE: Extracellular matrix (ECM) changes are prevalent in a number of diseases. The precise mechanisms by which changes in the ECM contribute to disease progression is unclear, primarily due to absence of appropriate models. Here, using glaucoma as a disease model, we document changes in cell derived matrix (CDM) and tissue mechanics that contribute to the pathology. Subsequently, we determine the effect that ECMs from diseased and healthy individuals have on healthy cell behaviors. Data emanating from this study demonstrate that CDMs are a potent tool for the study of cell-ECM interactions.

Indexed as

AgedAged, 80 and overEndoplasmic Reticulum StressExtracellular MatrixFemaleFibronectinsGene Expression RegulationGlaucomaHumansMaleMiddle AgedTrabecular MeshworkTranscription, GeneticFibronectinsAtomic force microscopyBiomechanicsCell derived matricesExtracellular matrixGlaucomaMechanotransductionTrabecular meshwork

Identifiers

PMID29524673
PMCPMC5899949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.